Equity Research, Broker Reports, and media content on Beximco Pharmaceuticals Limited Sponsored GDR RegS

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Beximco Pharmaceuticals Limited Sponsored GDR RegS
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Beximco Pharmaceuticals Limited Sponsored GDR RegS

Company Profile

  • Personnel
  • Ahmed Sohail Fasiur Rahman, Chairman
  • Nazmul Hassan, CEO
  • Ali Nawaz, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Beximco Pharmaceuticals Limited Sponsored GDR RegS. We currently have 63 research reports from 3 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 30.9/110p
  • Daily Volume: N/A
  • Daily Liquidity: (0.01%)
  • # Shares: 405.6m
  • Market Cap: £374.7m
  • Latest PE (hist): 0.00
  • Div Yield: 1.92
Date Source Announcement
30Apr21 07:00 RNS Q3 Financial Results
28Apr21 07:00 RNS Update on the supply of COVID-19 vaccine
24Mar21 16:41 RNS Second Price Monitoring Extn
24Mar21 16:36 RNS Price Monitoring Extension
24Mar21 14:06 RNS Second Price Monitoring Extn
24Mar21 14:00 RNS Price Monitoring Extension
24Mar21 11:06 RNS Second Price Monitoring Extn
  • Frequency of research reports

     

  • Research reports on

    Beximco Pharmaceuticals Limited Sponsored GDR RegS

  • Providers covering

    Beximco Pharmaceuticals Limited Sponsored GDR RegS